Human Medicines European Public Assessment Report (EPAR): Cymbalta, Duloxetine, Anxiety Disorders,Diabetic Neuropathies,Depressive Disorder, Major, Date of Authorisation: 17/12/2004, Revision: 26, Status: Authorised
Case Medical Research
doi 10.31525/cmr-12043e6